流感病毒神经氨酸酶/唾液酸酶:其特征,命名,活性测量,动力学,作为治疗剂的抑制剂

Q Pharmacology, Toxicology and Pharmaceutics Anales De La Real Academia Nacional De Farmacia Pub Date : 2022-12-31 DOI:10.53519/analesranf.2022.88.05.07
José Antonio Cabezas Fernández del Campo
{"title":"流感病毒神经氨酸酶/唾液酸酶:其特征,命名,活性测量,动力学,作为治疗剂的抑制剂","authors":"José Antonio Cabezas Fernández del Campo","doi":"10.53519/analesranf.2022.88.05.07","DOIUrl":null,"url":null,"abstract":"The main characteristics of neuraminidase / sialidase from Influenza Virus and its peculiar nomenclature are described, as well as two new, sensitive and simple procedures (fluorometric and by luminiscence) for measuring neuraminidase activity, which have been used at the Department of Biochemistry and Molecular Biology of the University of Salamanca (Prof. J. A. Cabezas). The kinetics of neuraminidase of three A and three B Influenza Virus Strains, and the result of the comparison of biological and physical properties of human and animal origin (pig and duck) Virus Strains, belonging to the same subtype A(H1N1), are described. Finally, the advantages and risks for the use as therapeutic agents against Influenza of the Influenza Virus neuraminidase inhibitors Zanamivir, Oseltamivir and Peramivir are discussed.\n\nKeywords: neuraminidase / sialidase; influenza virus; inhibitors","PeriodicalId":50795,"journal":{"name":"Anales De La Real Academia Nacional De Farmacia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Neuraminidase / sialidase from influenza virus: its characteristics, nomenclature, measuring of activity, kinetics, inhibitors as therapeutic agents\",\"authors\":\"José Antonio Cabezas Fernández del Campo\",\"doi\":\"10.53519/analesranf.2022.88.05.07\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main characteristics of neuraminidase / sialidase from Influenza Virus and its peculiar nomenclature are described, as well as two new, sensitive and simple procedures (fluorometric and by luminiscence) for measuring neuraminidase activity, which have been used at the Department of Biochemistry and Molecular Biology of the University of Salamanca (Prof. J. A. Cabezas). The kinetics of neuraminidase of three A and three B Influenza Virus Strains, and the result of the comparison of biological and physical properties of human and animal origin (pig and duck) Virus Strains, belonging to the same subtype A(H1N1), are described. Finally, the advantages and risks for the use as therapeutic agents against Influenza of the Influenza Virus neuraminidase inhibitors Zanamivir, Oseltamivir and Peramivir are discussed.\\n\\nKeywords: neuraminidase / sialidase; influenza virus; inhibitors\",\"PeriodicalId\":50795,\"journal\":{\"name\":\"Anales De La Real Academia Nacional De Farmacia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anales De La Real Academia Nacional De Farmacia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53519/analesranf.2022.88.05.07\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anales De La Real Academia Nacional De Farmacia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53519/analesranf.2022.88.05.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

介绍了流感病毒神经氨酸酶/唾液酸酶的主要特征及其特殊命名法,以及萨拉曼卡大学生物化学和分子生物学系(J.A.Cabezas教授)使用的两种新的、灵敏和简单的神经氨酸酶活性测定方法(荧光法和发光法)。介绍了三株甲型和三株乙型流感病毒的神经氨酸酶动力学,以及属于同一亚型甲型H1N1的人源性和动物源性(猪和鸭)病毒株的生物学和物理特性的比较结果。最后,讨论了流感病毒神经氨酸酶抑制剂Zanamivir、Oseltamivir和Peramivir作为流感治疗剂的优势和风险。关键词:神经氨酸酶/唾液酸酶;流感病毒;抑制剂
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Neuraminidase / sialidase from influenza virus: its characteristics, nomenclature, measuring of activity, kinetics, inhibitors as therapeutic agents
The main characteristics of neuraminidase / sialidase from Influenza Virus and its peculiar nomenclature are described, as well as two new, sensitive and simple procedures (fluorometric and by luminiscence) for measuring neuraminidase activity, which have been used at the Department of Biochemistry and Molecular Biology of the University of Salamanca (Prof. J. A. Cabezas). The kinetics of neuraminidase of three A and three B Influenza Virus Strains, and the result of the comparison of biological and physical properties of human and animal origin (pig and duck) Virus Strains, belonging to the same subtype A(H1N1), are described. Finally, the advantages and risks for the use as therapeutic agents against Influenza of the Influenza Virus neuraminidase inhibitors Zanamivir, Oseltamivir and Peramivir are discussed. Keywords: neuraminidase / sialidase; influenza virus; inhibitors
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.13
自引率
0.00%
发文量
7
期刊介绍: The Anales de la Real Academia Nacional de Farmacia� embraces all aspects of pharmaceutical sciences and is a quarterly journal that publishes basic and applied research on pharmaceutical sciences and related areas. It is a medium for reporting selected original and significant contributions to new pharmaceutical knowledge.
期刊最新文献
Therapeutic repositioning: importance of new therapeutic indications approved for old medicines The mRNA COVID 19 vaccine: More than a drug? Detection and management of a case of drug-resistant hypertension Galenic development of a capsule containing rosuvastatin, repaglinide, and olmesartan mini-tablets for the treatment of metabolic syndrome Novel drugs recently authorized by ema and fda (Q2, 2024)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1